BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11267530)

  • 41. Does growth hormone treatment affect the risk of post-transplant renal cancer?
    Mehls O; Wilton P; Lilien M; Berg U; Broyer M; Rizzoni G; Waldherr R; Opelz G
    Pediatr Nephrol; 2002 Dec; 17(12):984-9. PubMed ID: 12520324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advanced native kidney renal cell carcinoma in renal transplant recipients: role of sirolimus as dual anti-cancer and anti-rejection agent.
    Javaid MM; Chowdhury S; Henderson A; Olsburgh J
    Clin Nephrol; 2013 Feb; 79(2):154-60. PubMed ID: 23364206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of donor melanoma in a renal transplant recipient.
    Wilson LJ; Horvat RT; Tilzer L; Meis AM; Montag L; Huntrakoon M
    Diagn Mol Pathol; 1992 Dec; 1(4):266-71. PubMed ID: 1364174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Partial nephrectomy for renal cell carcinoma in long-term renal allografts: operative and post-operative considerations.
    Cox A; Nguan CY; Luke PP
    Can J Urol; 2005 Dec; 12(6):2887-90. PubMed ID: 16401374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal cell carcinoma of the native kidney after renal transplantation. A case report and review of the literature.
    Ishikawa I; Ishii H; Shinoda A; Tateishi K; Ben A; Suzuki K; Tsugawa R
    Nephron; 1991; 58(3):354-8. PubMed ID: 1896101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival Outcomes in Renal Transplant Recipients With Renal Cell Carcinoma or Transitional Cell Carcinoma From the ANZDATA Database.
    Ranasinghe WK; Suh N; Hughes PD
    Exp Clin Transplant; 2016 Apr; 14(2):166-71. PubMed ID: 26669303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inadvertent transfer of choriocarcinoma with renal transplantation: characteristics of the donor-recipient pairs.
    Doutrelepont JM; Mat O; Abramowicz D; Piccart M; Kerger J; De Pauw L; Vereertstraeten P; Vanherweghem JL; Kinnaert P
    Transplant Proc; 1995 Apr; 27(2):1789-90. PubMed ID: 7725506
    [No Abstract]   [Full Text] [Related]  

  • 48. [Melanoma in organ transplant patients].
    Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
    Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
    Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
    Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
    Bhat M; Mara K; Dierkhising R; Watt KDS
    Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Risk of cancer in patients following chronic dialysis and kidney graft].
    Janus N; Launay-Vacher V; Ferrero JM; Thariat J
    Bull Cancer; 2012 Mar; 99(3):285-93. PubMed ID: 22381360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquired cystic kidney disease and renal cell cancer after transplantation: time to rethink screening?
    Scandling JD
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):621-2. PubMed ID: 17699473
    [No Abstract]   [Full Text] [Related]  

  • 53. Fate of a renal tubulopapillary adenoma transmitted by an organ donor.
    Barrou B; Bitker MO; Delcourt A; Ourahma S; Richard F
    Transplantation; 2001 Aug; 72(3):540-1. PubMed ID: 11502993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review.
    Katabathina VS; Menias CO; Tammisetti VS; Lubner MG; Kielar A; Shaaban A; Mansour J; Surabhi VR; Hara AK
    Radiographics; 2016; 36(5):1390-407. PubMed ID: 27618321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal cell carcinoma in an allograft kidney transplant.
    Heinz-Peer G; Helbich T; Nöttling B; Klauser R; Mühlbacher F; Hübsch P
    Transplantation; 1994 Feb; 57(3):475-8. PubMed ID: 8108890
    [No Abstract]   [Full Text] [Related]  

  • 56. Malignant tumours following immunosuppression in renal transplantation.
    Birkeland SA; Kemp E
    Proc Eur Dial Transplant Assoc; 1973; 10(0):429-33. PubMed ID: 4370181
    [No Abstract]   [Full Text] [Related]  

  • 57. [Two cases of renal cell carcinoma arising in the native kidney following renal transplantation--clinical study and review of 26 cases reported in Japan].
    Fukatsu T; Nishikawa A; Yonemura S; Onishi T; Kinbara H; Arima K; Yanagawa M; Sugimura Y
    Hinyokika Kiyo; 2004 Feb; 50(2):81-5. PubMed ID: 15101161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study.
    Fattouh K; Ducroux E; Decullier E; Kanitakis J; Morelon E; Boissonnat P; Sebbag L; Jullien D; Euvrard S
    Transpl Int; 2017 Nov; 30(11):1172-1180. PubMed ID: 28700114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunosuppression due to lymphoma, organ transplant increases risk of melanoma.
    Oncology (Williston Park); 2012 Nov; 26(11):1073, 1077-8. PubMed ID: 23330350
    [No Abstract]   [Full Text] [Related]  

  • 60. Transmission of cancer from organ donors.
    Penn I
    Ann Transplant; 1997; 2(4):7-12. PubMed ID: 9869872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.